Mindfulness-Based Psychoeducation Improves Mindfulness and Medication Adherence in Schizophrenia: A Randomized Controlled Trial
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 40
- Locations
- 2
- Primary Endpoint
- Mindfulness level (Mindful Attention Awareness Scale)
Study Overview
Brief Summary
This study aims to examine the effects of a mindfulness-based psychoeducation program on mindfulness levels and treatment adherence among individuals diagnosed with schizophrenia. Schizophrenia is a chronic psychiatric disorder that affects thinking, emotions, and behavior, and difficulties in adhering to prescribed treatments are commonly observed. Poor treatment adherence is associated with relapse, increased hospitalization, and reduced overall functioning.
This randomized controlled study includes 40 patients assigned to either an experimental group or a control group. The experimental group receives a structured mindfulness-based psychoeducation program, while the control group receives treatment as usual without any additional intervention. Assessments are conducted before and after the intervention using a Personal Information Form, a Mindfulness Scale, and the Morisky Medication Adherence Scale.
Detailed Description
Schizophrenia is a severe and chronic psychiatric disorder characterized by disturbances in thought processes, perceptions, emotions, and behaviors. Despite advances in pharmacological and psychosocial treatments, maintaining long-term treatment adherence remains a major challenge in the management of schizophrenia. Non-adherence to treatment is associated with adverse clinical outcomes, including relapse, rehospitalization, impaired functioning, and increased healthcare utilization.
Mindfulness-based interventions have been increasingly applied in mental health settings to support awareness of internal experiences, emotional regulation, and stress management. Mindfulness practices may contribute to treatment engagement by enhancing individuals' awareness of symptoms, daily routines, and coping responses. Psychoeducation is a core component of psychiatric nursing care and focuses on improving knowledge about illness, treatment processes, and coping strategies. Integrating mindfulness practices into a psychoeducation framework may offer a structured approach to supporting treatment engagement in individuals with schizophrenia.
Study Purpose
The primary purpose of this randomized controlled trial is to evaluate the effects of a structured mindfulness-based psychoeducation program on:
Mindfulness levels Treatment adherence among individuals diagnosed with schizophrenia. Study Design
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Diagnosis of schizophrenia according to DSM-5 criteria
- •Age between 18-65 years
- •Being clinically stable for at least the past 3 months
- •Able to communicate, read, and understand Turkish
- •Receiving outpatient psychiatric follow-up
- •Willingness to participate and providing informed consent
Exclusion Criteria
- •Presence of acute psychotic symptoms requiring immediate hospitalization
- •Comorbid intellectual disability, neurological disorder, or severe cognitive impairment
- •Substance or alcohol dependence within the last 6 months
- •Participation in any mindfulness-based or psychoeducational program within the last year
- •Severe visual or hearing impairment preventing participation
- •Any condition judged by the clinician to contraindicate participation in group sessions
Outcomes
Primary Outcomes
Mindfulness level (Mindful Attention Awareness Scale)
Time Frame: Baseline and 8 weeks after intervention
Mindfulness was assessed using the Mindful Attention Awareness Scale (MAAS). Score range: 15-90. Higher scores indicate greater mindfulness.
Secondary Outcomes
- Mindfulness level at 8 weeks (Mindful Attention Awareness Scale)(8 weeks)
- Self-compassion level at 8 weeks (Self-Compassion Scale)(8 weeks)
Investigators
Ömer USLU
Dr. Ömer Uslu, PhD - Principal Investigator
Aydin Adnan Menderes University